-
-
-
-
-
-
-
Spyre Therapeutics Announces Proposed Public Offering of its Common Stock
-
-
-
-
-
-
-
Spyre Therapeutics Announces Pricing of $275.0 Million Public Offering of Common Stock
-
-
-
-
-
-
-
Spyre Therapeutics Announces Proposed Public Offering of its Common Stock and Pre-Funded Warrants
-
-
-
-
-
72,322 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

